Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patients
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.18929 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Matthew Y Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Western Precinct, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Rectal Neoplasms, Body Composition, Artificial Intelligence, Neoadjuvant Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
Background
The treatment of locally advanced rectal cancer (LARC) is moving towards total neoadjuvant therapy and potential organ preservation. Of particular interest are predictors of pathological complete response (pCR) that can guide personalized treatment. There are currently no clinical biomarkers which can accurately predict neoadjuvant therapy (NAT) response but body composition (BC) measures present as an emerging contender. The primary aim of the study was to determine if artificial intelligence (AI) derived body composition variables can predict pCR in patients with LARC.
Methods
LARC patients who underwent NAT followed by surgery from 2012 to 2023 were identified from the Australian Comprehensive Cancer Outcomes and Research Database registry (ACCORD). A validated in‐house pre‐trained 3D AI model was used to measure body composition via computed tomography images of the entire Lumbar‐3 vertebral level to produce a volumetric measurement of visceral fat (VF), subcutaneous fat (SCF) and skeletal muscle (SM). Multivariate analysis between patient body composition and histological outcomes was performed.
Results
Of 214 LARC patients treated with NAT, 22.4% of patients achieved pCR. SM volume ( P = 0.015) and age ( P = 0.03) were positively associated with pCR in both male and female patients. SCF volume was associated with decreased likelihood of pCR ( P = 0.059).
Conclusion
This is the first study in the literature utilizing AI‐measured 3D Body composition in LARC patients to assess their impact on pathological response. SM volume and age were positive predictors of pCR disease in both male and female patients following NAT for LARC. Future studies investigating the impact of body composition on clinical outcomes and patients on other neoadjuvant regimens such as TNT are potential avenues for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Western Precinct, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Colorectal Surgery, Western Health, Melbourne, Victoria, Australia.
- Gibbs Lab, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.
- Department of Medical Oncology, Western Health, Melbourne, Victoria, Australia.
ORCID-Profile: Matthew Y Wei
Zitieren
APA
Wei, M. Y., Cao, K., Hong, W., Yeung, J., Lee, M., Gibbs, P., Faragher, I. G., Baird, P. N., & Yeung, J. M. (2024). Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patients. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18929
Vancouver
Wei MY, Cao K, Hong W, Yeung J, Lee M, Gibbs P, et al. Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patients. ANZ Journal of Surgery. 2024. doi:10.1111/ans.18929
BibTeX
@article{Wei2024,
author = {Wei, Matthew Y and Cao, Ke and Hong, Wei and Yeung, Josephine and Lee, Margaret and Gibbs, Peter and Faragher, Ian G and Baird, Paul N and Yeung, Justin M},
title = {Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patients},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.18929}
}
EUVIMED